These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 31670586

  • 1. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
    Wang Y, Shen Y, Hu X, Li Z, Feng C, Hu D, Kamel IR.
    AJR Am J Roentgenol; 2020 Feb; 214(2):383-389. PubMed ID: 31670586
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G, Chen X, Zhang J, Zhu J, Zong G, Wang Z.
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
    Feng C, Wang Y, Dan G, Zhong Z, Karaman MM, Li Z, Hu D, Zhou XJ.
    Eur Radiol; 2022 Feb; 32(2):890-900. PubMed ID: 34342693
    [Abstract] [Full Text] [Related]

  • 5. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ, Pui MH, Guo Y, Li SR, Guan J, Zhang XL, Cai HS.
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [Abstract] [Full Text] [Related]

  • 6. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    Wang F, Wu LM, Hua XL, Zhao ZZ, Chen XX, Xu JR.
    J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
    [Abstract] [Full Text] [Related]

  • 7. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L, Wen Z, Cai Q, Lin Y, Chen Y, Cao W, Li M, Qian L, Chen J, Guo Y, Wang H.
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [Abstract] [Full Text] [Related]

  • 8. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.
    Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J, Lin H, Zhang Z, Hu D.
    Medicine (Baltimore); 2016 Mar; 95(10):e2951. PubMed ID: 26962794
    [Abstract] [Full Text] [Related]

  • 9. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S, Ponhold L, Heinz-Peer G, Fajkovic H, Haitel A, Susani M, Shariat SF, Szarvas T, Baltzer PA.
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [Abstract] [Full Text] [Related]

  • 10. Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer.
    Li S, Liang P, Wang Y, Feng C, Shen Y, Hu X, Hu D, Meng X, Li Z.
    Abdom Radiol (NY); 2021 Sep; 46(9):4301-4310. PubMed ID: 33909091
    [Abstract] [Full Text] [Related]

  • 11. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.
    Yoshida S, Koga F, Kobayashi S, Ishii C, Tanaka H, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e21-7. PubMed ID: 22414281
    [Abstract] [Full Text] [Related]

  • 12. [Application of apparent diffusion coefficient ratio in the diagnosis of bladder cancer grading pre-operation].
    Zhou GX, Wang YB, Hao NX, Wu YW, Zhu JQ, Wang B, Wang ZQ, Tao XF.
    Zhonghua Yi Xue Za Zhi; 2013 Oct 08; 93(37):2953-6. PubMed ID: 24401582
    [Abstract] [Full Text] [Related]

  • 13. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results.
    Rosenkrantz AB, Mussi TC, Spieler B, Melamed J, Taneja SS, Huang WC.
    J Magn Reson Imaging; 2012 Jun 08; 35(6):1478-83. PubMed ID: 22282396
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.
    Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K.
    Eur Radiol; 2011 Oct 08; 21(10):2178-86. PubMed ID: 21688007
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Zhang X, Guo J, Yun Y, Shan D, Yang D, Xu C, Chen X.
    Acad Radiol; 2024 Oct 08; 31(10):4076-4084. PubMed ID: 38548534
    [Abstract] [Full Text] [Related]

  • 16. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F, Chen HG, Zhang RY, Jin D, Xu SS, Wu GY, Xu JR.
    Eur Radiol; 2019 Aug 08; 29(8):4447-4455. PubMed ID: 30666451
    [Abstract] [Full Text] [Related]

  • 17. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
    Zhang X, Wang Y, Zhang J, Xu X, Zhang L, Zhang M, Xie L, Shou J, Chen Y.
    Abdom Radiol (NY); 2022 Jun 08; 47(6):2148-2157. PubMed ID: 35306580
    [Abstract] [Full Text] [Related]

  • 18. Quantitative Assessment of Bladder Cancer Reflects Grade and Recurrence: Comparing of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Li H, Liu L, Ding L, Zhang Z, Zhang M.
    Acad Radiol; 2019 Sep 08; 26(9):1148-1153. PubMed ID: 30503834
    [Abstract] [Full Text] [Related]

  • 19. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
    Rosenkrantz AB, Haghighi M, Horn J, Naik M, Hardie AD, Somberg MB, Melamed J, Xiao GQ, Huang WC, Taouli B.
    AJR Am J Roentgenol; 2013 Dec 08; 201(6):1254-9. PubMed ID: 24261364
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
    Zhang YD, Wu CJ, Wang Q, Zhang J, Wang XN, Liu XS, Shi HB.
    AJR Am J Roentgenol; 2015 Aug 08; 205(2):W193-201. PubMed ID: 26204307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.